Patient-reported outcomes on a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate-risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy (NCT#01101451)

IF 4.1 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Gynecologic oncology Pub Date : 2025-09-01 DOI:10.1016/j.ygyno.2025.03.054

Dana Chase , Helen Huang , Wei Deng , William Rodgers , William Small Jr. , Kevin Albuquerque , Jyoti Mayadev , Charles Leath , Bradley Monk , Beob-Jong Kim , Dae-Yeon Kim , Chi-Heum Cho , Jae-Weon Kim , Jae Hong No , Laura Holman , Ashley Stuckey , Denise Fabian , Alexandra Smick , Lari Wenzel , Karen Gil , Sang Young Ryu

引用次数: 0

查看原文本刊更多论文

一项随机III期临床试验的患者报告结果：辅助放疗与放化疗对初始根治性子宫切除术和盆腔淋巴结切除术治疗的中度风险I/IIA期宫颈癌（NCT#01101451）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic oncology 医学-妇产科学

CiteScore

8.60

自引率

6.40%

发文量

1062

审稿时长

37 days

期刊介绍： Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy